10-Q: Hercules Capital Reports Q2 2025 Financial Results
Quarterly Report
Hercules Capital, Inc. reported a significant increase in total investment income and net assets for the six months ended June 30, 2025, driven by portfolio growth and strategic financing activities, despite a net realized loss.
Summary
- Total investment income for the six months ended June 30, 2025, increased to $257.0 million from $246.6 million in the prior year period.
- Net investment income for the six months ended June 30, 2025, rose to $166.2 million, up from $161.5 million in the same period last year.
- Net increase in net assets resulting from operations for the six months ended June 30, 2025, was $129.2 million, compared to $132.8 million in the prior year period.
- The company reported a net realized loss of $59.2 million for the six months ended June 30, 2025, primarily from debt investment write-offs and foreign exchange losses.
- Net change in unrealized appreciation was $22.2 million for the six months ended June 30, 2025, a positive shift from $31.1 million in net unrealized depreciation in the prior year period.
- The total fair value of the investment portfolio increased to $4,176.5 million as of June 30, 2025, from $3,660.0 million as of December 31, 2024.
- Investment commitments originated by Hercules Capital and Adviser Funds totaled $2,019.8 million for the six months ended June 30, 2025.
- Gross debt fundings by Hercules Capital and Adviser Funds reached $1,239.9 million for the six months ended June 30, 2025.
- The company received $414.4 million in aggregate principal repayments during the six months ended June 30, 2025, with $399.2 million from early repayments.
- PIK interest income for the six months ended June 30, 2025, was $27.1 million, an increase from $25.2 million in the prior year period, with the ending PIK interest receivable balance at $84.1 million.
- Unfunded contractual commitments available at the request of portfolio companies totaled $471.5 million as of June 30, 2025.
- The asset coverage ratio under regulatory requirements was 222.2% excluding SBA debentures, and 202.2% including SBA debentures, as of June 30, 2025.
- The company declared total distributions of $0.94 per share for the six months ended June 30, 2025, comprised of ordinary income.
- Approximately 97.8% of the debt investment portfolio had floating interest rates with a floor as of June 30, 2025.
Sentiment
Score: 7
Explanation: The company shows strong growth in investment income and portfolio size, indicating robust operational performance. While there was a net realized loss, it's offset by positive unrealized appreciation and overall net asset growth. The significant capital raises and healthy liquidity position suggest a positive outlook, despite some yield compression and increased cash usage in operations.
Positives
- Total investment income increased to $257.0 million for the six months ended June 30, 2025, up from $246.6 million in the prior year, indicating strong revenue generation.
- Net investment income grew to $166.2 million for the six months ended June 30, 2025, compared to $161.5 million in the prior year, demonstrating improved profitability from core operations.
- The total fair value of the investment portfolio expanded significantly to $4,176.5 million as of June 30, 2025, from $3,660.0 million at year-end 2024, reflecting robust investment activity.
- Net assets increased to $2.2 billion with a Net Asset Value (NAV) per share of $11.84 as of June 30, 2025, up from $11.66 at December 31, 2024.
- The company maintained a strong asset coverage ratio of 222.2% (excluding SBA debentures) and 202.2% (including SBA debentures) as of June 30, 2025, indicating healthy financial leverage.
- The ATM program generated substantial net proceeds of $188.9 million for the six months ended June 30, 2025, providing significant capital for investments and general corporate purposes.
- Approximately 97.8% of the debt investment portfolio is at floating rates with a floor, providing insulation against declining interest rates.
- The fair value of the warrant portfolio increased by $5.0 million to $35.5 million as of June 30, 2025, indicating potential for future capital appreciation.
- The company actively manages over $5.3 billion in assets, including through its Adviser Subsidiary, showcasing significant scale and reach in venture debt and life sciences financing.
Negatives
- The company reported a net realized loss of $59.2 million for the six months ended June 30, 2025, primarily due to write-offs of debt investments in Khoros, LLC and Annex Cloud, and the sale of AmplifyBio, LLC.
- Fee income decreased to $11.8 million for the six months ended June 30, 2025, from $13.3 million in the prior year period, mainly due to lower acceleration of fee income from early repayments.
- Cash used in operating activities increased significantly to $367.0 million for the six months ended June 30, 2025, compared to $181.4 million in the prior year, indicating higher cash outflows for operations and investments.
- The weighted average core yield on debt investments decreased to 12.5% for the three months ended June 30, 2025, from 13.7% in the prior year period.
- The weighted average effective yield on debt investments decreased to 13.9% for the three months ended June 30, 2025, from 14.7% in the prior year period.
- The PIK interest receivable balance increased to $84.1 million as of June 30, 2025, from $67.7 million at the beginning of the period, indicating a growing portion of non-cash interest income.
Risks
- Financial results could be negatively affected if a significant portfolio investment fails to perform as expected, given that the top six portfolio companies represent over 5% of net assets each.
- The capital markets are subject to fluctuations from inflation, interest rate movements, slowing economic growth, and geopolitical events, which could impact financial position, results of operations, or cash flows.
- The company's ability to originate new investments, achieve certain margins and profitability, and maintain certain debt to asset ratios depends on various assumptions that could differ from actual results.
- Information technology system failures, data security breaches, data privacy compliance issues, network disruptions, and cybersecurity attacks could materially adversely affect the business.
- The fair value of investments, particularly those without readily available market values, involves significant judgment and inherent uncertainty, and actual realized values could differ materially.
- Operating as a Business Development Company (BDC) and Small Business Investment Company (SBIC) subjects the company to various regulatory requirements and oversight, including limitations on investment types and leverage.
- The company's ability to issue common stock at a price below Net Asset Value (NAV) is restricted without prior stockholder approval, which may limit capital raising flexibility.
Future Outlook
The company expects to continue to generate cash flows from operations, including income from investments, with primary uses of funds being new portfolio investments and cash distributions. It plans to continue using debt and proceeds from portfolio turnover and equity offerings to finance investment objectives. The company will monitor macroeconomic market developments and their impact on its business and portfolio companies, believing it is well-positioned to manage the current environment due to its focus on resilient industries and floating rate debt with interest rate floors.
Management Comments
- We are committed to providing equal opportunity in all employment practices and will not tolerate harassment, violence, intimidation, and discrimination.
- We require honest and accurate recording and reporting of information in all financial books, records, and accounts.
- Our Chief Executive Officer, or his or her designee, is the sole contact for media seeking information about the Company.
- Employees are prohibited from discussing or posting information regarding the Company in any external electronic forum, including Internet chat rooms, electronic bulletin boards or social media sites.
- Employees are responsible for compliance with the Code of Business Conduct and Ethics and are required to report violations promptly, with no reprisal for good faith reporting.
Industry Context
Hercules Capital operates in the specialty finance sector, focusing on high-growth, innovative venture capital-backed and institutional-backed companies, primarily in technology and life sciences. This niche allows the company to target sectors characterized by high margins, high growth rates, consolidation, and product/market extension opportunities. The company's strategy of primarily investing in debt securities with floating rates and interest rate floors positions it to manage interest rate fluctuations, a key trend in the current macroeconomic environment. Its significant assets under management and active investment origination reflect its leading position in providing financing solutions to these dynamic industries.
Comparison to Industry Standards
- The company's investment strategy focuses on high-growth, innovative venture capital-backed and institutional-backed companies, primarily in technology and life sciences, which aligns with a specialized segment of the broader financial services industry that targets high-potential, often intangible-asset-rich, businesses.
- The company's use of senior secured loans, often collateralized by intellectual property, is a common practice in venture debt, differentiating it from traditional bank lending or public market investments.
- The company's practice of obtaining warrants or other equity securities alongside debt investments is standard for venture debt providers, aiming to capture additional upside from successful portfolio companies, similar to venture capital firms.
- The company's reliance on internal valuation processes for Level 3 assets, corroborated by independent valuation firms, is a standard practice for illiquid alternative investments, though the inherent subjectivity means valuations can differ from market prices if a liquid market existed.
- The company's asset coverage ratio of 222.2% (excluding SBA debentures) and 202.2% (including SBA debentures) indicates a conservative leverage profile compared to some other financial institutions, reflecting its BDC regulatory requirements and risk management approach.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adoption/Update | Joint Code of Ethics and Code of Business Conduct and Ethics became effective on June 6, 2025, establishing standards for ethical practices, conflicts of interest, confidentiality, fair dealing, and compliance with laws. | 2025-06-06 | Enhances corporate governance framework by formalizing ethical standards and compliance procedures for all employees, officers, and directors, aiming to prevent conflicts of interest and ensure adherence to securities laws. |
| Policy Adoption/Update | Insider Trading Policy was amended and restated on September 19, 2024, and further amended in March 2025, providing guidelines on handling material non-public information and trading restrictions. | 2024-09-19 | Strengthens controls against insider trading, protecting the company's reputation and ensuring compliance with securities laws, with specific procedures for pre-clearance and handling sensitive information. |
Legal Proceedings
- The company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise.
- Third parties may try to seek to impose liability on the company in connection with the activities of its portfolio companies.
- The company does not expect any current matters to materially affect its financial condition or results of operations, but provides no assurance that future proceedings will not have a material adverse effect.
Related Party Transactions
- The Adviser Subsidiary, a wholly-owned registered investment adviser, provides investment advisory and management services to Adviser Funds in exchange for asset-based fees and potential incentive fees.
- The company has a shared services agreement with the Adviser Subsidiary, allocating related expenses for human capital resources and infrastructure, with $3.4 million and $6.7 million allocated for the three and six months ended June 30, 2025, respectively.
- As of June 30, 2025, approximately $1.2 million was receivable from the Adviser Subsidiary.
- Investment commitments assigned to or directly committed by the Adviser Funds totaled $437.6 million for the six months ended June 30, 2025.
- Investment fundings assigned to, directly originated or funded by the Adviser Funds totaled $275.8 million for the six months ended June 30, 2025.
- The company received $6.0 million from the Adviser Funds relating to assigned investments for the six months ended June 30, 2025.
Stakeholder Impact
- Shareholders: Potential for continued distributions, but also exposure to investment losses and dilution from equity offerings. Net asset value per share increased.
- Employees: Subject to updated Codes of Ethics and Business Conduct, and Insider Trading Policy, which define standards of conduct and reporting requirements.
- Customers (Portfolio Companies): Benefit from continued access to financing solutions, including new commitments and fundings, but are subject to strict loan terms and performance expectations.
- Creditors: Debt obligations are being managed, with new debt issuances and repayments, and the company maintains strong asset coverage ratios, indicating ability to meet obligations.
- Regulatory Authorities: The company continues to comply with SEC and SBA regulations as a BDC and SBIC, including reporting and asset coverage requirements.
Next Steps
- Continue to make investments in portfolio companies.
- Pay quarterly cash distributions to stockholders.
- Evaluate overall liquidity position and take proactive steps to maintain appropriate liquidity.
- Monitor macroeconomic market developments and their related impact to the business and portfolio companies.
- Manage unfunded contractual commitments, which may expire without being drawn.
Key Dates
| Date | Description |
|---|---|
| 2003-11 | Hercules Technology SBIC Management, LLC (HTM) was formed. |
| 2003-12 | Hercules Capital, Inc. was incorporated in Maryland. |
| 2005-05-17 | Articles of Amendment and Restatement previously filed. |
| 2006-01-01 | Company elected to be treated as a Regulated Investment Company (RIC) for U.S. federal income tax purposes. |
| 2007-03-06 | Articles of Amendment dated March 6, 2007. |
| 2010-12 | Hercules Capital IV, L.P. (HC IV) was formed. |
| 2011-04-05 | Articles of Amendment dated April 5, 2011. |
| 2014-07-16 | July 2024 Notes fully repaid. |
| 2015-04-03 | Articles of Amendment dated April 3, 2015. |
| 2016-02-23 | Articles of Amendment dated February 23, 2016. |
| 2017-03-31 | Company's investment in Tectura Corporation became classified as a control investment. |
| 2018-03-31 | Company's investment in Gibraltar Acquisition LLC became classified as a control investment. |
| 2018-06-28 | 2018 Equity Incentive Plan and 2018 Non-Employee Director Plan approved by stockholders. |
| 2018-09-04 | Board approved application of 150% minimum asset coverage ratio. |
| 2018-09-24 | Company issued $40.0 million of 6.250% unsecured notes due October 30, 2033 (2033 Notes). |
| 2018-12-06 | Stockholders approved application of 150% minimum asset coverage ratio. |
| 2019-07-16 | Company issued $105.0 million of 4.770% unsecured notes due July 16, 2024 (July 2024 Notes). |
| 2020-02-05 | Company issued $50.0 million of 4.280% unsecured notes due February 5, 2025 (February 2025 Notes). |
| 2020-06-03 | Company issued $70.0 million of 4.310% unsecured notes due June 3, 2025 (June 2025 Notes). |
| 2020-10-27 | HC IV received its license to operate as a Small Business Investment Company (SBIC). |
| 2020-11-04 | Company issued $50.0 million of 4.500% unsecured notes due March 4, 2026 (March 2026 A Notes). |
| 2021-03-04 | Company issued $50.0 million of 4.550% unsecured notes due March 4, 2026 (March 2026 B Notes). |
| 2021-09-16 | Company issued $325.0 million of 2.625% unsecured notes due September 16, 2026 (September 2026 Notes). |
| 2021-12-31 | Company's investment in Coronado Aesthetics, LLC became classified as a control investment. |
| 2022-01-20 | Company issued $350.0 million of 3.375% unsecured notes due January 20, 2027 (January 2027 Notes). |
| 2022-06-22 | Company completed a term debt securitization, issuing $150.0 million of 4.950% asset-backed notes due July 20, 2031 (2031 Asset-Backed Notes). |
| 2022-06-23 | Company issued $50.0 million of 6.000% unsecured notes due June 23, 2025 (June 2025 3-Year Notes). |
| 2023-08-07 | Company sold 6.5 million shares of common stock through an upsized public offering. |
| 2023-10-30 | 2033 Notes became redeemable at the company's option. |
| 2024-02-06 | Board declared a supplemental cash distribution of $0.28 per share to be paid in four quarterly distributions of $0.07 per share. |
| 2024-02-08 | Board declared Q1 2024 cash distribution of $0.40 per share and supplemental cash distribution of $0.08 per share. |
| 2024-03-06 | Q1 2024 cash distribution and supplemental cash distribution paid. |
| 2024-04-25 | Board declared Q2 2024 cash distribution of $0.40 per share and supplemental cash distribution of $0.08 per share. |
| 2024-05-21 | Q2 2024 cash distribution and supplemental cash distribution paid. |
| 2024-07-09 | Hercules SBIC V, L.P. (SBIC V) received its license to operate as a Small Business Investment Company (SBIC). |
| 2024-07-20 | Reinvestment period for 2031 Asset-Backed Notes ended. |
| 2024-07-25 | Board declared Q3 2024 cash distribution of $0.40 per share and supplemental cash distribution of $0.08 per share. |
| 2024-08-20 | Q3 2024 cash distribution and supplemental cash distribution paid. |
| 2024-10-24 | Board declared Q4 2024 cash distribution of $0.40 per share and supplemental cash distribution of $0.08 per share. |
| 2024-11-20 | Q4 2024 cash distribution and supplemental cash distribution paid. |
| 2024-11-26 | Company entered into a fifth amendment to its revolving credit agreement with Sumitomo Mitsui Banking Corporation (SMBC Facility). |
| 2024-12-12 | Company entered into 2024 Equity Distribution Agreements with Citizens JMP Securities LLC and Jefferies LLC. |
| 2025-02-05 | February 2025 Notes fully repaid. Company entered into Third Amendment to SMBC Letter of Credit Facility Agreement. |
| 2025-02-06 | Board declared Q1 2025 cash distribution of $0.40 per share and supplemental cash distribution of $0.07 per share. |
| 2025-03-05 | Q1 2025 cash distribution and supplemental cash distribution paid. |
| 2025-03-10 | Company issued $287.5 million of 4.750% convertible unsecured notes due September 1, 2028 (2028 Convertible Notes). |
| 2025-04-23 | Board declared Q2 2025 cash distribution of $0.40 per share and supplemental cash distribution of $0.07 per share. |
| 2025-05-20 | Q2 2025 cash distribution and supplemental cash distribution paid. |
| 2025-06-03 | June 2025 Notes fully repaid. |
| 2025-06-06 | Joint Code of Ethics and Code of Business Conduct and Ethics became effective. |
| 2025-06-10 | Company entered into a fourth amended credit facility agreement with MUFG Bank Ltd. (MUFG Bank Facility). |
| 2025-06-16 | Company issued $350.0 million of 6.000% unsecured notes due June 16, 2030 (June 2030 Notes). |
| 2025-06-23 | June 2025 3-Year Notes fully repaid. |
| 2025-07-24 | Board declared Q3 2025 cash distribution of $0.40 per share and supplemental cash distribution of $0.07 per share. |
| 2025-08-12 | Record date for Q3 2025 cash and supplemental distributions. |
| 2025-08-19 | Payment date for Q3 2025 cash and supplemental distributions. |
| 2025-09-25 | $65.0 million of drawn SBA Debentures are scheduled to be pooled. |
| 2028-05-12 | 2018 Equity Incentive Plan and Director Plan terminate unless earlier terminated by the Board. |
| 2028-09-01 | Maturity date for 2028 Convertible Notes. |
| 2028-11-24 | Availability under the revolving SMBC Facility will terminate. |
| 2029-06-10 | Maturity date for MUFG Bank Facility. |
| 2029-11-26 | Outstanding loans under the SMBC Facility will mature. |
| 2030-06-16 | Maturity date for June 2030 Notes. |
| 2031-07-20 | Maturity date for 2031 Asset-Backed Notes. |
| 2033-10-30 | Maturity date for 2033 Notes. |
| 2034-07 | Various premises leases expire. |
Recommendation
holdHercules Capital demonstrates strong operational performance with increased investment income and portfolio growth, supported by successful capital raises. The healthy asset coverage ratio and high percentage of floating-rate debt with floors provide stability. However, the net realized loss and slight decrease in yields warrant a cautious approach. While the long-term outlook appears positive given its market position, the current environment suggests a 'hold' as the company navigates potential macroeconomic headwinds and integrates new investments.
Keywords
Venture Debt, BDC, RIC, SEC Filing, Investment Portfolio, Financial Results, Debt Investments, Equity Investments, Warrants, Asset Management, Capital Raise, Interest Rates, Unfunded Commitments, Technology Sector, Life Sciences
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.